Glaukos announced that its latest technologies will be featured across multiple scientific sessions at the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting, taking place April 10-13, 2026, in Washington, D.C. The company will exhibit its portfolio of products and pipeline innovations at booth #407. In addition to its exhibition presence, Glaukos will sponsor an educational symposium in partnership with ASCRS and EyeWorld titled, “Introducing Epioxa, the first and only FDA-approved, epithelium-on, oxygen-enriched corneal cross-linking treatment.” The session is scheduled for Friday, April 10, from 12:00–1:00 p.m. ET in Room 102 AB at the Walter E. Washington Convention Center. The symposium will be moderated by Brandon D. Ayres, MD, and feature a panel of experts including Kenneth A. Beckman, MD; Maanasa Indaram, MD; and Matt Jensen, MBA. The program will highlight clinical insights and advancements in corneal cross-linking therapies, particularly focusing on the newly approved Epioxa treatment. Scientific Presentations Highlight Pipeline and Clinical Progress Glaukos-supported research will also be presented in several key sessions throughout the meeting, emphasizing advancements in glaucoma and corneal health: Saturday, April 11 1:40–1:45 p.m. — Arkadiy Yadgarov, MD: 12-Month Outcomes of Standalone Third-Generation Trabecular Micro-Bypass Stents in Eyes with Open-Angle Glaucoma 2:01–2:06 p.m. — Michael B. Raizman, MD: Design Review and Clinical Plan for Novel Keratoconus Screening Device Sunday, April 12 1:40–1:45 p.m. — Jasmin Kaur / Savak Teymoorian, MD: 12-Month Single-Center Outcomes of Travoprost Intracameral Implant in Eyes with Open-Angle Glaucoma or Ocular Hypertension 3:35–3:40 p.m. — Lisa K. Feulner, MD: Real-World Outcomes of Combining Trabecular Micro-Bypass Stents with Intracameral Travoprost Implant or Cataract Surgery On-Demand Posters Showcase Additional Clinical Data A series of on-demand poster presentations will further detail clinical outcomes and safety data related to Glaukos technologies. Topics include the durability of epithelium-on corneal cross-linking, combination therapies involving trabecular micro-bypass stents and travoprost implants, and long-term outcomes in glaucoma patients undergoing minimally invasive procedures. Contributing authors include Kenneth A. Beckman, MD; John P. Berdahl, MD; Christine N. Funke, MD; Steven R. Sarkisian Jr., MD; and Zachary D. Vest, MD. Abstracts and additional meeting information are available through the official ASCRS annual meeting website.
